The World Health Organization (WHO) Committee on Genetic Engineering focuses on the global regulation, ethics, and implementation of gene-editing technologies, including CRISPR and synthetic biology. This committee will focus on evaluating current policies and developing new ones to ensure safe and ethical use of gene editing and gene therapy as it becomes more prominent in the medical field. Delegates will evaluate how these tools can be safely and equitably applied to improve public health outcomes worldwide.
Single-Delegate Committee
There are no Position Papers required for this committee
Director:
Polina Evdokimova
Chair: Coming Soon!